ALDX News

Bronstein, Gewirtz & Grossman LLC Urges Aldeyra Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Pomerantz LLP Alerts Shareholders to Investor Suit Against Aldeyra Therapeutics, Inc. – ALDX

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX

ALDX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026

ALDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by The Firm - ALDX

Pomerantz LLP Calls Attention to Class Action Against Aldeyra Therapeutics, Inc. – ALDX

Pomerantz LLP Advises Shareholders of Class Action Involving Aldeyra Therapeutics, Inc. – ALDX

ALDX INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026 Ready to Announce with Confidence?

Pomerantz LLP Alerts Shareholders to Investor Suit Involving Aldeyra Therapeutics, Inc. – ALDX